What is Hapbee?
Founded in 2019, Hapbee operates at the intersection of biotechnology and consumer electronics. The company specializes in the development of wearable devices that utilize patented ultra-low radio frequency energy (ulRFE) to influence user states, such as focus, relaxation, and alertness. By delivering low-power electromagnetic signals, Hapbee offers a non-invasive alternative to traditional wellness interventions. The firm's market position is defined by its unique intellectual property and its ability to translate complex biophysical research into accessible, consumer-facing hardware available through its direct-to-consumer platform.
How much funding has Hapbee raised?
Hapbee has raised a total of $15M across 5 funding rounds:
Share Placement
$8M
Share Placement
$1.1M
Share Placement
$2.8M
Share Placement
$2M
Stock/Share Issuance
$1.1M
Share Placement (2022): $8M, investors not publicly disclosed
Share Placement (2022): $1.1M, investors not publicly disclosed
Share Placement (2024): $2.8M, investors not publicly disclosed
Share Placement (2024): $2M, investors not publicly disclosed
Stock/Share Issuance (2025): $1.1M, investors not publicly disclosed
Key Investors in Hapbee
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Hapbee?
With the infusion of this latest capital, Hapbee is positioned to transition into a more aggressive phase of enterprise-level scaling. Strategic priorities likely include the refinement of its ulRFE signal library, expansion of its manufacturing capabilities, and the pursuit of broader distribution partnerships. As the company matures, the focus will shift toward long-term sustainability and the potential integration of its technology into broader health-tracking ecosystems. Investors will be monitoring the firm's ability to maintain its technological edge while navigating the regulatory and consumer adoption challenges inherent in the emerging neuro-wellness market.
See full Hapbee company page
